{
  "id": 1469,
  "text": "31), respectively), and the incidence of thrombocytopenia with CCRT (cisplatin $^ +$ gemcitabine) was higher $\\mathrm { { O R } = 4 .4 4 }$ $[ 9 5 \\% \\mathrm { C I } = 1 .6 3 \\ – 1 2 .0 7 )$ ).In terms of gastrointestinal toxicity, the incidence of diarrhea and vomiting with CCRT (cisplatin $^ +$ gemcitabine) was higher than CCRT (cisplatin) $\\mathrm { \\Delta O R } = 3 .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 31), respectively), and the incidence of thrombocytopenia with CCRT (cisplatin $^ +$ gemcitabine) was higher $\\mathrm { { O R } = 4 .4 4 }$ $[ 9 5 \\% \\mathrm { C I } = 1 .6 3 \\ – 1 2 .0 7 )$ ).In terms of gastrointestinal toxicity, the incidence of diarrhea and vomiting with CCRT (cisplatin $^ +$ gemcitabine) was higher than CCRT (cisplatin) $\\mathrm { \\Delta O R } = 3 .\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "使用顺铂联合吉西他滨的同步放化疗方案在治疗过程中常见的副作用包括血小板减少症、腹泻和呕吐。研究显示，与仅使用顺铂的方案相比，这种联合方案引起这些副作用的几率更高。血小板减少症可能导致出血风险增加，而腹泻和呕吐则会影响患者的消化系统功能，可能导致电解质失衡和营养不良。因此，在使用这种治疗方案时，医务人员通常需要密切监测患者的血液指标和消化系统状态，以及时进行相应的对症处理。",
  "query": "使用顺铂联合吉西他滨的同步放化疗方案在治疗过程中会导致哪些常见的副作用？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 使用顺铂联合吉西他滨的同步放化疗方案在治疗过程中会导致哪些常见的副作用？\n\n<reference text>: 31), respectively), and the incidence of thrombocytopenia with CCRT (cisplatin $^ +$ gemcitabine) was higher $\\mathrm { { O R } = 4 .4 4 }$ $[ 9 5 \\% \\mathrm { C I } = 1 .6 3 \\ – 1 2 .0 7 )$ ).In terms of gastrointestinal toxicity, the incidence of diarrhea and vomiting with CCRT (cisplatin $^ +$ gemcitabine) was higher than CCRT (cisplatin) $\\mathrm { \\Delta O R } = 3 .\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "使用顺铂联合吉西他滨的同步放化疗方案在治疗过程中常见的副作用包括血小板减少症、腹泻和呕吐。研究显示，与仅使用顺铂的方案相比，这种联合方案引起这些副作用的几率更高。血小板减少症可能导致出血风险增加，而腹泻和呕吐则会影响患者的消化系统功能，可能导致电解质失衡和营养不良。因此，在使用这种治疗方案时，医务人员通常需要密切监测患者的血液指标和消化系统状态，以及时进行相应的对症处理。"
}